PEBP1 and ovarian carcinoma: By detection ELISA assays, polyclonal antibodies (pAb) against the N-terminal (anti-PEBP1 N-term pAb), the center of PEBP1 (anti-PEBP1 center pAb), and the whole protein (anti-PEBP1 pAb), detected the presence of PEBP1 in 29 out of 30 ovarian cancer ascites, including ascites from ovarian cancers of non-serous origin (fig.